Zhou Dong-Kai, Qian Xiao-Hui, Cheng Jun, Chen Ling-Hui, Wang Wei-Lin
Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province.
Medicine (Baltimore). 2019 Nov;98(48):e17815. doi: 10.1097/MD.0000000000017815.
To study the clinical significance of HINT2 expression in patients with HCC.We investigated HINT2 mRNA expression in tumors and adjacent non-tumor hepatic tissues from 106 HCC patients using quantitative real-time PCR. Appropriate statistical methods were then applied to assess the relationships between the HINT2 mRNA level and clinical parameters.HINT2 was significantly down-regulated in HCC (P < .0001). No significant correlation was found between HINT2 expression and clinicopathological factors in HCC patients. A Kaplan-Meier survival curve showed that HINT2 expression is related to recurrence-free survival (P < .05). Multivariate analyses revealed that tumor size and HINT2 expression are risk factors for HCC recurrence.HINT2 is down-regulated in HCC, and low HINT2 expression predicts earlier tumor recurrence. HINT2 expression may serve as a prognostic indicator of recurrence in HCC.
为研究HINT2表达在肝癌患者中的临床意义。我们采用定量实时PCR检测了106例肝癌患者肿瘤组织及癌旁非肿瘤肝组织中HINT2 mRNA的表达。随后应用适当的统计方法评估HINT2 mRNA水平与临床参数之间的关系。HINT2在肝癌中显著下调(P<0.0001)。在肝癌患者中,未发现HINT2表达与临床病理因素之间存在显著相关性。Kaplan-Meier生存曲线显示,HINT2表达与无复发生存相关(P<0.05)。多因素分析显示,肿瘤大小和HINT2表达是肝癌复发的危险因素。HINT2在肝癌中下调,低HINT2表达预示肿瘤复发较早。HINT2表达可能作为肝癌复发的预后指标。